ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biobased Chemicals

Corteva invests in Israeli microbe firm

by Melody M. Bomgardner
August 9, 2019 | APPEARED IN VOLUME 97, ISSUE 32

 

Corteva Agriscience, which spun off of DowDuPont in June, is expanding its biological product offerings by investing in an arm of Israel’s Evogene. Corteva will invest cash and shares of its own Taxon Biosciences subsidiary in Evogene’s Lavie Bio subsidiary in return for a 30% stake in Lavie. The firms will integrate their pipelines of microbial and biochemical products; Corteva will market them for corn and soybeans. The companies have collaborated for 2 years.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment